MedTrace Logo

Intravenous Iron May Increase Depression Among Hemodialysis Patients

NCT03157050 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 112

Last updated 2017-05-17

No results posted yet for this study

Summary

the aim of this study is to assess whether increased ferritin after intravenous iron therapy will lead to increased prevalence of major depression among treated patients.

Conditions

Interventions

OTHER

Intravenous iron therapy

each patient with iron def anemia received an IV syringe of iron sucrose 100 mg every dialysis session for 10 doses

Sponsors & Collaborators

  • New Jeddah Clinic Hospital

    collaborator INDUSTRY

  • Benha University

    lead OTHER

Principal Investigators

  • Mahmoud Hamada, MD · Benha University

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-14
Primary Completion
2017-05-15
Completion
2017-05-16

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03157050 on ClinicalTrials.gov